AcelRx Pharma (ACRX) Posts Suprise Q3 Profit

AcelRx Pharma (NASDAQ: ACRX) reported Q3 EPS of $0.01, $0.24 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $13.9 million versus the consensus estimate of $1.75 million.

For earnings history and earnings-related data on AcelRx Pharma (ACRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c